Magnitude and Determinants of Weight Loss Response to GLP-1/GIP Receptor Agonists in India: A Real-World Time-to-Event Analysis

Introduction: Obesity and type 2 diabetes (T2D) are rapidly increasing in India. Although newer glucagon-like peptide/glucose-dependent insulinotropic polypeptide (GLP-1/GIP) receptor agonists have demonstrated considerable efficacy in weight loss, real-world evidence from the Indian population is l...

Descripción completa

Detalles Bibliográficos

Autores principales:	Godana Jarso, Shama Mahendru, Aditya Dutta, Rutuja Sharma, Abebe Megerso, Ambrish Mithal
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2026-03-01
Colección:	Indian Journal of Endocrinology and Metabolism
Materias:	diabetes glp1/gip receptor agonists obesity semaglutide tirzepatide weight loss
Acceso en línea:	https://journals.lww.com/10.4103/ijem.ijem_1085_25
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!